Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search
Back to Resource Library

PrEP Drug Interaction Checker

8 May 2026

This website, developed and maintained by the University of Liverpool, provides clear, trustworthy, and up-to-date information about how different PrEP options, including oral PrEP, cabotegravir, lenacapavir, and the dapivirine vaginal ring, can interact with other drugs.

Topic(s): Research, Service Delivery

Product(s): Cabotegravir, Dapivirine Vaginal Ring, F/TAF, Injectable Prep, Lenacapavir, Oral PrEP, TDF/xTC

Format(s): External Link

Source(s): University of Liverpool

Type: External Link

Visit

Featured Resources

Document

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.
Document

Zambia Guidelines for Pre and Post-Exposure Prophylaxis for HIV Infection, 2025

These clinical guidelines, developed by Zambia’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR), as well as the Dual Prevention Pill and oral PrEP.
Document

LEN Rollout Resources and Tools

The resources listed in this document, alongside insights drawn from the report Getting PrEP Rollout Right This Time, can support countries in the early stages of LEN planning. These tools are being disseminated as part of a coordinated effort between AVAC, CHAI, CIFF, the Global Fund, PEPFAR, PSI, Unitaid, Wits RHI, and WHO under the…
Document

HIV Prevention Ambassador Training Package and Toolkit

The HIV Prevention Ambassador Training Package and Toolkit was created to prepare potential and current PrEP users to be leaders – or “Ambassadors” – in the rollout of PrEP for HIV prevention in their communities. Through interactive activities, discussion, and action planning, the training prepares Ambassadors to share information with their peers about PrEP methods…
External Link

Early Experiences with Usage of Long-acting Injectable Cabotegravir among Adults in Rural Ugandan and Kenyan Communities: Qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

This article from Journal of the International AIDS Society describes the results of a qualitative study exploring experiences with injectable cabotegravir (CAB for PrEP) among adults participating in the SEARCH Dynamic Choice HIV Prevention (DCP) trial in rural Kenya and Uganda, which evaluated HIV prevention uptake through a structured, person-centred DCP model.
Document

PrEP Clinical Reporting Tools

This suite of clinical reporting forms, developed by South Africa’s National Department of Health, can be used for PrEP reporting, including injectable lenacapavir (LEN). The download folder includes forms for PrEP initiation, continuation, pregnancy outcome reporting, and seroconversion reporting.
External Link

Lenacapavir Training Videos

These videos, developed by South Africa’s National Department of Health, can be used to train providers offering injectable lenacapavir (LEN) for PrEP, and include modules on screening, initiation, counselling, follow-up, side effects, special considerations, and reporting.
Spreadsheet

Lenacapavir Implementation Planning Tool

This tool, developed by South Africa’s National Department of Health, can be used to develop action plans for facilities introducing injectable lenacapavir (LEN).
External Link

GBGMC Country Profiles

These country profiles provide concise, actionable snapshots of the HIV prevention and treatment landscape for key populations across multiple countries, including: Brazil, Eswatini, France, Kenya, Malawi, Mozambique, Nigeria, the Philippines, South Africa, Uganda, Ukraine, the United States, Vietnam, Zambia, and Zimbabwe. Country profiles highlight: History of PrEP introduction Updates on PrEP Products Key population epidemiology…
External Link

Integrated Study Dashboard

This dashboard, produced under the BioPIC project, reflects all currently known activities relating to implementation research, modelling, clinical research, and landscaping for new late stage biomedical HIV PrEP options, including lenacapavir for PrEP, cabotegravir, and the dapivirine vaginal ring. To update or add any activities missing from the dashboard, or if you have questions on…